Abstract:DTNBP1, which encodes dysbindin-1, is associated with cognitive impairment. Genetic evidence indicates that the C allele of rs117610176 leads to an increase in DTNBP-1b mRNA splicing in patients with paranoid schizophrenia. In addition, dysbindin-1B, rather than dysbindin-1A/C, exhibits a tendency toward toxic aggregation. In postmortem brains, dysbindin-1B not only aggregates with itself, it also co-aggregates with proteins that interact with it. However, the pathogenic mechanism underlying dysbindin-1B toxic aggregation remains unknown. In the brain, dysbindin-1 is primarily found as a subunit of biogenesis of lysosome-related organelles complex 1 (BLOC-1), which plays a role in intracellular vesicle trafficking. Therefore, we hypothesized that dysbindin-1B might impair the cognitive function of schizophrenia patients by co-aggregating with BLOC-1 subunits and disturbing the function of BLOC-1. In this study, we investigated the dominant-negative effect of dysbindin-1B on the BLOC-1 complex. We found that in multiple brain areas in Dys1B(+/+) mice, the expression levels of soluble functional BLOC-1 subunits were decreased. Meanwhile, BLOC-1 subunits co-aggregated with dysbindin-1B-myc. Functional studies in primary cortical neurons further revealed the malfunction of BLOC-1 in intercellular vesicle trafficking in Dys1B(+/+) mice. In addition, we used the Morris water maze task to investigate the effects of dysbindin-1B aggregation on cognition. The results demonstrated that Dys1B(+/+) mice exhibited spatial learning and memory deficits, which were accompanied by the shrinkage of apical and basal dendritic branches and the loss of dendritic spines in hippocampal CA1 neurons, as demonstrated by Golgi staining. Taken together, the results of the present study suggest that dysbindin-1B toxic aggregation might impair cognition through a dominant-negative effect on BLOC-1.

Dysbindin Regulates Hippocampal Ltp by Controlling Nmda Receptor Surface Expression

Role of Dysbindin in Dopamine Receptor Trafficking and Cortical Gaba Function

Loss of Dysbindin Implicates Synaptic Vesicle Replenishment Dysregulation as a Potential Pathogenic Mechanism in Schizophrenia

Dysbindin-1 Mutation Alters Prefrontal Cortex Extracellular Glutamate and Dopamine In Vivo

Nucleocytoplasmic Shuttling of Dysbindin-1, a Schizophrenia-related Protein, Regulates Synapsin I Expression

Dysbindin-1, BDNF, and GABAergic Transmission in Schizophrenia.

Schizophrenia Susceptibility Gene Dysbindin Regulates Glutamatergic and Dopaminergic Functions Via Distinctive Mechanisms in Drosophila

Dysbindin-1, BDNF, and GABAergic Transmission in Schizophrenia

Striatal dopamine release in a schizophrenia mouse model measured by electrochemical amperometry in vivo.

The Pathogenic Mechanism of Dysbindin-1b Toxic Aggregation: Bloc-1 and Intercellular Vesicle Trafficking

DTNBP1, a Schizophrenia Susceptibility Gene, Affects Kinetics of Transmitter Release.

Increased Dysbindin-1B Isoform Expression in Schizophrenia and Its Propensity in Aggresome Formation

DREAM (downstream Regulatory Element Antagonist Modulator) Contributes to Synaptic Depression and Contextual Fear Memory

Advances in the Studies of the Dysbindin Gene in Schizophrenia

NMDA Receptor Hypofunction Induces Dysfunctions of Energy Metabolism and Semaphorin Signaling in Rats: a Synaptic Proteome Study.

The Schizophrenia-Related Protein Dysbindin-1a is Degraded and Facilitates Nf-Kappa B Activity in the Nucleus

Deubiquitinase CYLD regulates excitatory synaptic transmission and short-term plasticity in the hippocampus

Synaptic Protein DLG2 Controls Neurogenic Transcriptional Programs Disrupted in Schizophrenia and Related Disorders

Behavioral Deficits and Subregion-Specific Suppression of LTP in Mice Expressing a Population of Mutant NMDA Receptors Throughout the Hippocampus

Protein Kinase B/Akt1 Phosphorylates Dysbindin-1A at Serine 10 to Regulate Neuronal Development

N-methyl-D-aspartate Receptor Subunit 1 Regulates Neurogenesis in the Hippocampal Dentate Gyrus of Schizophrenia-Like Mice